Study of the graphene oxide nanoparticles effect on luminol-dependent chemiluminescence of human leukocytes

Graphene and its derivatives are increasingly used in biomedical research. Therefore, the mechanisms and consequences of the interaction of graphene nanoparticles with living objects are intensively studied. The immune system is involved in protecting the body and regulating its functions, so the question of the effect of graphene and its derivatives on immune cells is crucial. The specific response of monocytes, macrophages, and neutrophils to a stimulus is to increase the production of reactive oxygen species (ROS). Published data on graphene oxide (GO) and polyethylene glycol-modified graphene oxide (GO-PEG) effects on peripheral blood leukocytes are scarce and contradictory. It is due to variations in objects and conditions of study, along with the difference in particle concentrations. Thus, it was essential to evaluate the GO and GO-PEG effect on ROS production by human leukocytes. Our study aimed at the effect of particles of unmodified and PEG-modified graphene oxide (GO and GO-PEG) on the ROS production by peripheral blood leukocytes in not-stimulated and stimulated luminoldependent chemiluminescence (LCL) tests. ROS production was stimulated by opsonized zymosan (OZ). A hydrogen peroxide-luminol system was used for assessing the independent effect of GO nanoparticles on the quenching of ROS luminescence. Pristine GO (Ossila, Great Britain) nanoparticles were PEG-modified (GO-PEG). The average size of the GO flakes was 1-5 µm, the GO-PEG-flakes 569±14 nm, and the amount of PEG covering was ~ 20%. Nanoparticles were used at concentrations of 5; 2.5; 1.25 µg/ml. It has been established that GO-PEG nanoparticles in concentrations of 2.5 and 5 µg/ml suppressed ROS production in the spontaneous LCL test. At the same time, the GO effects showed a visible but a not significant tendency to inhibition of LCL. Similar results were obtained in the stimulated LCL test. However, when analyzing the process kinetics, both GO-PEG and GO decreased the ROS production, but mainly in the first minutes of the test. When analyzing the quenching effect of the LCL reaction in a cell-free system, there was no significant effect of GO and GO-PEG nanoparticles. Thus, the general vector of the obtained effects was associated with the suppression of ROS production. GO-PEG ROS-decreasing effects were more pronounced in comparison with unmodified GO. In general, we have confirmed the antioxidant effects of GO and GO-PEG using the LCL method. We can assume that in addition to the actual antioxidant effect of graphene nanoparticles, ROS production decreases due to the rapid GO uptake and blocking of several intracellular signals that induce an oxidative burst.

1. Baali N., Khecha A., Bensouici A., Speranza G., Hamdouni N. Assessment of Antioxidant Activity of Pure Graphene Oxide (GO) and ZnO-Decorated Reduced Graphene Oxide (rGO) Using DPPH Radical and H2O2 Scavenging Assays. Journal of Carbon Research, 2019, Vol. 5, pp. 75.

2. Bedouhène S., Moulti-Mati F., Hurtado-Nedelec M., Dang P. M., El-Benna J. Luminol-amplified chemiluminescence detects mainly superoxide anion produced by human neutrophils. American journal of blood research, 2017, Vol. 7, no. 4, pp. 41–48.

3. Bi S., Zhao T., Luo B. A graphene oxide platform for the assay of biomolecules based on chemiluminescence resonance energy transfer. Chemical Communications, 2012, Vol. 48, iss.1, pp. 106-108.

4. Han J., Kim Y.S., Lim M.Y., Kim H.Y., Kong S., Kang M., Choo Y.W., Jun J.H., Ryu S., Jeong H.Y., Park J., Jeong G.J., Lee J.C., Eom G.H., Ahn Y., Kim B.S. Dual Roles of Graphene Oxide To Attenuate Inflammation and Elicit Timely Polarization of Macrophage Phenotypes for Cardiac Repair. ACS Nano., 2018, Vol. 12, pp. 1959−1977.

5. Kelly E.K., Wang L., Ivashkiv L.B. (2010). Calcium-activated pathways and oxidative burst mediate zymosan-induced signaling and IL-10 production in human macrophages. Journal of immunology, 2010, Vol. 184, iss. 10. pp. 5545-5552.

6. Lee, M.Y., Kim, S.Y., Kim, H.G., In, I. Chemiluminescence quenching of luminol-functionalized chemically reduced graphene oxide through noncovalent interaction. Chemistry Letters, 2013, Vol. 42, no.1, pp. 48-49.

7. Marković Z.M., Jovanović S.P., Mašković P.Z., Mojsin M.M., Stevanović M.J., Danko M., Mičušík M., Jovanović D.J., Kleinová A., Špitalský Z., Pavlović V.B., Todorović Marković B.M. Graphene oxide size and structure pro-oxidant and antioxidant activity and photoinduced cytotoxicity relation on three cancer cell lines. Journal of Photochemistry and photobiology. B, 2019, Vol. 200, Article 111647.

8. Mendes R.G., Mandarino A., Koch B., Meyer A.K., Bachmatiuk A., Hirsch C., Gemming T., Schmidt O.G., Liu Z., Rümmeli M.H. Size and time dependent internalization of label-free nano-graphene oxide in human macrophages. Nano Res., 2017, Vol. 10, pp. 1980–1995.

9. Nilewski L., Mendoza K., Jalilov A.S., Berka V., Wu G., Sikkema W.K.A., Metzger A., Ye R., Zhang R., Luong D. X., Wang T., McHugh E., Derry P.J., Samuel E. L., Kent T.A., Tsai A.L., Tour J.M. Highly Oxidized Graphene Quantum Dots from Coal as Efficient Antioxidants. ACS Appl. Mater. Interfaces., 2019, Vol. 11, iss. 18, pp. 16815-16821.

10. Povedailo V.A., Ronishenko B.V., Stepuro V.I., Tsybulsky D.A., Shmanai V.V., Yakovlev D.L. Fluorescence Quenching of Dyes by Graphene Oxide. Journal of Applied Spectroscopy, 2018, Vol. 85, pp. 605–610.

11. Qiu Y., Wang Z., Owens A.C., Kulaots I., Chen Y., Kane A.B., Hurt R.H. Antioxidant Chemistry of Graphene-Based Materials and its Role in Oxidation Protection Technology. Nanoscale, 2014, Vol. 6, iss. 20, pp. 11744−11755.

12. Ren C., Hu X., Zhou Q. Graphene Oxide Quantum Dots Reduce Oxidative Stress and Inhibit Neurotoxicity In Vitro and In Vivo through Catalase‐Like Activity and Metabolic Regulation. Advanced Science, 2018, Vol. 5, iss. 5, Article 1700595.

13. Ruiz V., Yate L., García I., Cabanero G., Grande H.J. Tuning the antioxidant activity of graphene quantum dots: Protective nanomaterials against dye decoloration. Carbon, 2017, Vol. 116, pp. 366-374.

14. Tabish T.A., Zhang S., Winyard P.G. Developing the next generation of graphene-based platforms for cancer therapeutics: The potential role of reactive oxygen species. Redox biology, 2018, Vol. 15, pp. 34–40.

15. Xu M., Zhu J., Wang F., Xiong Y., Wu Y., Wang Q., Weng J., Zhang Z., Chen W., Liu S. Improved In Vitro and In Vivo Biocompatibility of Graphene Oxide through Surface Modification: Poly(Acrylic Acid)-Functionalization is Superior to PEGylation. ACS Nano, 2016, Vol. 10, iss. 3, pp. 3267-3281.